JLE

Annales de Biologie Clinique

MENU

POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group Volume 79, issue 6, Novembre-Décembre 2021

Figures


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5

  • Figure 6

  • Figure 7

  • Figure 8

Tables

Authors
Marie-Christine Beauvieux Pour les membres du groupe de travail SFBC « Marqueurs biochimiques de la pathologie Covid-19 » 15
1 Hôpitaux universitaires de Strasbourg laboratoire de biochimie et biologie moléculaire, France
2 CHU d’Angers, laboratoire de biochimie et biologie moléculaire, France
3 CHRU de Tours, laboratoire de biochimie et biologie moléculaire, France
4 CHU Clermont-Ferrand, service de biochimie et génétique moléculaire, France
5 CHU de Marseille, biologie délocalisée, pôle biologie pathologie, France
6 AP-HP, hôpital Cochin, centre-université de Paris, service de diagnostic biologique automatisé, France
7 CHRU de Nancy, laboratoire de biochimie, France
8 Hôpital Foch, service de biologie clinique, SuresnesFrance
9 Centre hospitalier de Gonesse, laboratoire de biologie médicale, France
10 AP-HP, hôpital de la Pitié-Salpêtrière, laboratoire de biochimie, UF des urgences biologiques, ParisFrance
11 AP-HP, hôpital Saint-Antoine, laboratoire de biologie d’urgence, ParisFrance
12 Département de biochimie, Hôpital Tenon, AP-HP-Est, Paris, France
13 CHRU de Nancy, laboratoire d’hématologie, France
14 CHU de Bordeaux, cellule qualité, pôle biologie pathologie, France
15 CHU de Bordeaux, UMR5536 CNRS-université de Bordeaux, laboratoire de biochimie, France
* Correspondance

During the first wave of Covid-19 in France, in spring 2020, healthcare institution's laboratory had to adapt itself quickly to the growing demand for emergency biology, in particular by reorganizing their POCT analyzers: redeployment of analyzers and/or new installations. In order to analyze this management, a subgroup of 15 hospital biologists from the SFBC Working Group “Biochemical markers of Covid-19” sent, in fall 2020, an on-line survey to French hospital laboratories using POCT. Answers analysis (n = 86) shows a territorial disparity related to the severity of the first wave: increased activity essentially in red zones, management of unexpected situations, training of additional nursing staff for 40 % of the laboratories... The survey also showed simplification of aspects related to accreditation those periods of health crisis. An additional survey, carried out in the spring of 2021, showed good overall satisfaction of the healthcare services (n = 139) concerning the services provided by biology in the POCT sector. Because of their great adaptation capacity, the laboratories and their POCT-teams have played a key role in the management of the first wave of Covid-19 in France. However, the success of these organizations requires an essential collaboration between laboratories and healthcare services. The results of this survey are fundamental in the context of the prolongation of the pandemia throughout the world with a POCT sector appearing to be growing.